Barbra Johnson Sasu (Barbra J Sasu, Barbra Sasu)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Stem Cell Transplantation

Brain Metastases

Renal Cell Carcinoma

Endoplasmic Reticulum Stress

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research communications

Cancer research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Zhang, Silvia K Tacheva-Grigorova, Janette Sutton, Zea Melton, Yvonne S L Mak, Cecilia Lay, Bryan A Smith, Tao Sai, Thomas J Van Blarcom, Barbra Johnson Sasu, Siler H Panowski
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Regina J Lin, Janette Sutton, Trevor Bentley, Diego A Vargas-Inchaustegui, Duy Nguyen, Hsin-Yuan Cheng, Hayung Yoon, Thomas J Van Blarcom, Barbra Johnson Sasu, Siler H Panowski, Cesar Sommer
Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models. Science advances 9 (31) (2023)
Yi Zhang, Silvia K Tacheva-Grigorova, Janette Sutton, Zea Melton, Yvonne S L Mak, Cecilia Lay, Bryan A Smith, Tao Sai, Thomas J Van Blarcom, Barbra Johnson Sasu, Siler H Panowski
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Yi Zhang, Silvia K Tacheva-Grigorova, Janette Sutton, Zea Melton, Yvonne S L Mak, Cecilia Lay, Bryan A Smith, Tao Sai, Thomas J Van Blarcom, Barbra Johnson Sasu, Siler H Panowski
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Regina J Lin, Andrew R Nager, Spencer Park, Janette Sutton, Cecilia Lay, Zea Melton, Yi Zhang, Bijan Boldajipour, Thomas J Van Blarcom, Siler H Panowski, Barbra Johnson Sasu, Javier Chaparro-Riggers
Design and Validation of Inducible TurboCARs with Tunable Induction and Combinatorial Cytokine Signaling. Cancer immunology research 10 (9) (2022)
Ana M Metelo, Agnieszka Jozwik, Le Anh Luong, Delaney Dominey-Foy, Charlotte Graham, Charlotte Attwood, Shafqat Inam, Alan Dunlop, Katy Sanchez, Kirsty Cuthill, Carmel Rice, Matthew Streetly, Trevor Bentley, Bijan Boldajipour, Cesar Sommer, Barbra Johnson Sasu, Reuben Benjamin
Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors. Cancer research communications 2 (3) (2022)
Siler H Panowski, Surabhi Srinivasan, Nguyen Tan, Silvia K Tacheva-Grigorova, Bryan Smith, Yvonne S L Mak, Hongxiu Ning, Jonathan Villanueva, Dinali Wijewarnasuriya, Shanshan Lang, Zea Melton, Adit Ghosh, Mathilde Dusseaux, Roman Galetto, Jonathan R Heyen, Tao Sai, Thomas J Van Blarcom, Javier Chaparro-Riggers, Barbra Johnson Sasu
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma. Cancer research 82 (14) (2022)
Ana M Metelo, Agnieszka Jozwik, Le Anh Luong, Delaney Dominey-Foy, Charlotte Graham, Charlotte Attwood, Shafqat Inam, Alan Dunlop, Katy Sanchez, Kirsty Cuthill, Carmel Rice, Matthew Streetly, Trevor Bentley, Bijan Boldajipour, Cesar Sommer, Barbra Johnson Sasu, Reuben Benjamin
Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors. Cancer research communications 2 (3) (2022)
Spencer Park, Edward Pascua, Kevin C Lindquist, Christopher R Kimberlin, Xiaodi Deng, Yvonne S L Mak, Zea Melton, Theodore O Johnson, Regina Lin, Bijan Boldajipour, Robert T Abraham, Jaume Pons, Barbra Johnson Sasu, Thomas J Van Blarcom, Javier Chaparro-Riggers
Direct control of CAR T cells through small molecule-regulated antibodies. Nature communications 12 (1) (2021)